Bal Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 10/02/2022 to consider and approve Unaudited financial results (standalone & Consolidated) for the quarter ended 31.12.2021.
The above information is a part of company’s filings submitted to BSE.